IGF1R and Alzheimer disease: The results obtained with p44+/+;APP695/swe double-transgenics indicate that hyperactivation of IGF-1R signaling, as caused by deregulated longevity-assurance activity of p53:p44, can cause/accelerate an AD-like neuropathology in the mouse.